Z6尊龙
Other Affiliated Sites
Techdow Pharma China
Techdow Pharma UK
Techdow Pharma Poland
Techdow Pharma Italy
Techdow Pharma Spain
Techdow Pharma Germany
Techdow Pharma US
Cytovance Biologics
SPL
Simplified Chinese
Traditional Chinese
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
Global Industrial Chain
Global Heparin Injections Business
Product Profile
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Create Value for Investors Through
Safe and Stable Operations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Disclosures
A-Share Information
H-Share Information
Financial Reports
Announcements
2019.03.01
第四届董事会第二十次聚会决议通告
2019.03.01
第四届监事会第十五次聚会决议通告
2019.03.01
关于继续申请内保外贷暨为全资子公司提供反担保的通告
2019.03.01
关于使用自有资金购置低危害理工业品的通告
2019.02.28
2018年度业绩快报
2019.02.02
关于第三期员工持股妄想完成股票购置的通告
2019.01.29
关于第三期员工持股妄想的希望通告
2019.01.26
关于向及格投资者果真刊行公司债券获得中国证券监视治理委员会批准批复的通告
2019.01.18
关于控股子公司股权架构调解及对外融资的希望通告
2019.01.05
对控股子公司增资的希望通告
第一页
上一页
46
47
48
49
50
下一页
最后一页
About Hepalink
Group Profile
Corporate Philosophy
Milestones
Leadership Team
Scientific Advisory Board
Our Businesses
Heparin Business
CDMO Services
Innovative Drugs
Global Manufacturing
Company News
Investor Relations
Corporate Governance
Disclosures
Stock Information
IR Events
IR Contact
Join Us
Career Development
Job Opportunities
Campus Recruitment
Contact Us
Official WeChat Account
Legal Statement
·
Environmental Disclosure
Copyright ? 2024 Hepalink Group. All Rights Reserved.
【网站地图】
【sitemap】